# Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination

Notice 1bf40a0ad102443d8a4c34f0789d0f8c (solicitation HT9427-26-R-E020) from DEPT OF DEFENSE, DEFENSE HEALTH AGENCY, posted 2026-11-10, responses due 2026-11-20T17:00:00.000Z. Status: open.

| Field | Value |
| --- | --- |
| Notice ID | 1bf40a0ad102443d8a4c34f0789d0f8c |
| Solicitation number | HT9427-26-R-E020 |
| Type | Solicitation |
| Agency | DEPT OF DEFENSE |
| Sub-tier | DEFENSE HEALTH AGENCY (DHA) |
| Office | DEFENSE HEALTH AGENCY |
| Posted | 2026-11-10T16:03:49.000Z |
| Response deadline (UTC) | 2026-11-20T17:00:00.000Z |
| Set-aside | - |
| NAICS | 541715 |
| PSC | AN13 |
| Place of performance | Frederick, MD, USA |
| Award | - |

## Description

This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0003 only extends the proposal due date). Amendment 0001 – removed alternate point of contact information under “Contract Information” on SAM.gov Amendment 0002 – revised proposal due date from: 12:00pm eastern, Friday, 23 Oct 2026 to: 12:00pm eastern Friday, 06 Nov 2026 Amendment 0003 – revised proposal due date from: 12:00pm eastern Friday, 06 Nov 2026 to: 12:00pm eastern Friday, 20 Nov 2026

## Sources

- View on SAM.gov: https://sam.gov/opp/1bf40a0ad102443d8a4c34f0789d0f8c/view
- Data as of 2026-11-14. Source: https://sam.gov/data-services/Contract%20Opportunities/datagov

## Cite this

"Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination, SAM.gov contract opportunity 1bf40a0ad102443d8a4c34f0789d0f8c." samgovapi.io, https://samgovapi.io/opportunity/1bf40a0ad102443d8a4c34f0789d0f8c, data as of 2026-11-14. Primary record: https://sam.gov/opp/1bf40a0ad102443d8a4c34f0789d0f8c/view

## API and MCP

- REST: GET https://samgovapi.io/api/v1/opportunities/1bf40a0ad102443d8a4c34f0789d0f8c
- MCP tool: get_opportunity

Independent. Not affiliated with, endorsed by or sponsored by GSA, SAM.gov or any U.S. government agency. Registering in SAM.gov is free at sam.gov.

Get a free API key: https://samgovapi.io/sign-up?ref=ai-claudebot